Showing results (81-90 of 259) with videos related to
Sort By:
Pageof 26
Hinyokika Kiyo. Acta Urologica Japonica|November 21, 2009
[Renal cell carcinoma in a horseshoe kidney: a case report]Naokazu Ibuki, Hirofumi Uehara, Kazumasa Komura, et al.Diagnostics (Basel, Switzerland)|December 28, 2019
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral CarcinomaMakito Miyake, Nagaaki Marugami, Yuya Fujiwara, et al.Transplantation|October 15, 2003
Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allograftsHaruhito Azuma, Takashi Wada, Rieko Gotoh, et al.Plos One|April 7, 2017
Assessment of the ability of CT urography with low-dose multi-phasic excretory phases for opacification of the urinary systemHiroshi Juri, Takahiro Tsuboyama, Mitsuhiro Koyama, et al.International Journal of Clinical Pharmacology and Therapeutics|July 13, 2023
Platelet count and dose, but not comorbidities, predict severe neutropenia in cabazitaxel-treated prostate cancer patients: A retrospective observational studyNoriaki Kataoka, Takeo Hata, Kouichi Hosomi, et al.Journal of Neurosurgery|October 22, 2003
Transcriptional expression of survivin and its splice variants in brain tumors in humansYoshitaka Yamada, Toshihiko Kuroiwa, Toshimasa Nakagawa, et al.Hinyokika Kiyo. Acta Urologica Japonica|May 20, 2004
[Complete avulsion of ureter caused by abdominal blunt injury: a case report]Eikun Maruyama, Haruhito Azuma, Satoshi Kiyama, et al.International Journal of Oncology|November 3, 2018
Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancerHaruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.Case Reports in Transplantation|July 30, 2020
Effectiveness of Factor XIII Infusion in Treatment of Refractory Ureteral Leakage after Kidney TransplantationRyoichi Maenosono, Tomohisa Matsunaga, Hajime Hirano, et al.Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.Pageof 26